Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis

NCT00424346 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Canakinumab
DRUG: Placebo

Sponsor

Novartis